What is Cryofab?
Cryofab, Inc. is a distinguished leader in the design and manufacturing of cryogenic storage and transfer equipment. With a legacy spanning over five decades, the company serves critical sectors such as science, energy, and aerospace. Their comprehensive product portfolio includes cryogenic tanks, dewars, and transfer lines, alongside custom-engineered solutions designed to meet precise client specifications for liquid gases. Cryofab's commitment to high-quality manufacturing and innovative designs has cemented its global reputation, supported by robust customer service.
How much funding has Cryofab raised?
Cryofab has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Cryofab
PPP
Public-Private Partnership
What's next for Cryofab?
The substantial large-scale, late-stage funding indicates Cryofab is poised for significant expansion and further technological advancement. This strategic investment will likely fuel the enhancement of manufacturing capabilities, research and development into next-generation cryogenic solutions, and the broadening of its global market reach. The company's focus on providing solutions-oriented services suggests a continued emphasis on meeting the evolving demands of its diverse clientele in high-growth industries.
See full Cryofab company page
